Dow Jones

38,686.32

1.51%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
USOTC
PhaseBio Pharmaceuticals Inc (CE) (PHASQ)
PhaseBio Pharmaceuticals Inc (CE) (PHASQ) News

PhaseBio Pharmaceuticals (CE) (PHASQ)

PhaseBio Pharmaceuticals Inc (CE)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:PHASQ

Date	Time	Source	Headline	Symbol	Company
16/05/2024	21:32	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
16/05/2024	21:28	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
29/11/2023	21:55	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
15/11/2023	21:17	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
03/10/2023	12:17	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
27/09/2023	13:52	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
25/08/2023	17:34	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
25/08/2023	17:31	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
30/06/2023	21:21	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
30/05/2023	21:03	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
19/05/2023	21:19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
19/05/2023	21:19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
19/05/2023	21:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
19/05/2023	21:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
16/05/2023	21:23	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
03/04/2023	21:06	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
24/03/2023	12:08	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
14/02/2023	22:07	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
14/02/2023	20:01	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
14/02/2023	19:27	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
23/12/2022	13:34	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
21/12/2022	11:10	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
02/12/2022	21:20	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
15/11/2022	21:21	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
04/11/2022	20:44	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)